PharmaCyte Biotech Inc (PMCB)
Drugs • Health Care
Percentage
Change
| Aug 11 | Aug 12 | Jul 13 | Aug 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Aug 19 | Aug 20 | Aug 21 | Jul 22 | Jul 23 | Aug 24 | Aug 25 | Jul 26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income to Common | 23 | -23 | ||||||||||||||
Other Net Income Dilutions | -7 | -4 | ||||||||||||||
Net Income | 31 | -19 | ||||||||||||||
Profit | 31 | -19 | ||||||||||||||
Net Income Continuing | 31 | -19 | ||||||||||||||
Pretax Income | 31 | -19 | ||||||||||||||
Total Non-operating Income | 35 | -13 | ||||||||||||||
Operating Income | -4 | -7 | ||||||||||||||
Total Costs and Expenses | -4 | -7 | ||||||||||||||
Operating Expenses | -4 | -7 | ||||||||||||||
Impairment Expense | 0 | -2 | ||||||||||||||
Research and Development Expenses | -0 | -0 | ||||||||||||||
Selling, General & Administrative Expenses | -4 | -5 |